231 related articles for article (PubMed ID: 26932258)
1. Association between Parkinson's Disease and Helicobacter Pylori.
Çamcı G; Oğuz S
J Clin Neurol; 2016 Apr; 12(2):147-50. PubMed ID: 26932258
[TBL] [Abstract][Full Text] [Related]
2. Effects of Helicobacter pylori on Levodopa Pharmacokinetics.
Nyholm D; Hellström PM
J Parkinsons Dis; 2021; 11(1):61-69. PubMed ID: 33164946
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease.
Lee WY; Yoon WT; Shin HY; Jeon SH; Rhee PL
Mov Disord; 2008 Sep; 23(12):1696-700. PubMed ID: 18649391
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection is associated with a poor response to levodopa in patients with Parkinson's disease: a systematic review and meta-analysis.
Zhong R; Chen Q; Zhang X; Li M; Lin W
J Neurol; 2022 Feb; 269(2):703-711. PubMed ID: 33616741
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori infection is associated with an increased risk of Parkinson's disease: A population-based retrospective cohort study.
Huang HK; Wang JH; Lei WY; Chen CL; Chang CY; Liou LS
Parkinsonism Relat Disord; 2018 Feb; 47():26-31. PubMed ID: 29174171
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori infection is associated with worse severity of Parkinson's disease.
Tan AH; Mahadeva S; Marras C; Thalha AM; Kiew CK; Yeat CM; Ng SW; Ang SP; Chow SK; Loke MF; Vadivelu JS; Ibrahim N; Yong HS; Tan CT; Fox SH; Lang AE; Lim SY
Parkinsonism Relat Disord; 2015 Mar; 21(3):221-5. PubMed ID: 25560322
[TBL] [Abstract][Full Text] [Related]
7. Reduced L-dopa absorption and increased clinical fluctuations in Helicobacter pylori-infected Parkinson's disease patients.
Pierantozzi M; Pietroiusti A; Sancesario G; Lunardi G; Fedele E; Giacomini P; Frasca S; Galante A; Marciani MG; Stanzione P
Neurol Sci; 2001 Feb; 22(1):89-91. PubMed ID: 11487216
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori infection and Parkinson's Disease: etiology, pathogenesis and levodopa bioavailability.
Wei BR; Zhao YJ; Cheng YF; Huang C; Zhang F
Immun Ageing; 2024 Jan; 21(1):1. PubMed ID: 38166953
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of levodopa in patients with Parkinson disease and motor fluctuations depending on the presence of Helicobacter pylori infection.
Narożańska E; Białecka M; Adamiak-Giera U; Gawrońska-Szklarz B; Sołtan W; Schinwelski M; Robowski P; Madaliński MH; Sławek J
Clin Neuropharmacol; 2014; 37(4):96-9. PubMed ID: 24992088
[TBL] [Abstract][Full Text] [Related]
10. Microbial endocrinology as a basis for improved L-DOPA bioavailability in Parkinson's patients treated for Helicobacter pylori.
Lyte M
Med Hypotheses; 2010 May; 74(5):895-7. PubMed ID: 19962247
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations.
Pierantozzi M; Pietroiusti A; Brusa L; Galati S; Stefani A; Lunardi G; Fedele E; Sancesario G; Bernardi G; Bergamaschi A; Magrini A; Stanzione P; Galante A
Neurology; 2006 Jun; 66(12):1824-9. PubMed ID: 16801644
[TBL] [Abstract][Full Text] [Related]
12. The role of small intestinal bacterial overgrowth in Parkinson's disease.
Fasano A; Bove F; Gabrielli M; Petracca M; Zocco MA; Ragazzoni E; Barbaro F; Piano C; Fortuna S; Tortora A; Di Giacopo R; Campanale M; Gigante G; Lauritano EC; Navarra P; Marconi S; Gasbarrini A; Bentivoglio AR
Mov Disord; 2013 Aug; 28(9):1241-9. PubMed ID: 23712625
[TBL] [Abstract][Full Text] [Related]
13. Gastro-intestinal dysfunctions in Parkinson's disease (Review).
Ivan IF; Irincu VL; Diaconu Ș; Falup-Pecurariu O; Ciopleiaș B; Falup-Pecurariu C
Exp Ther Med; 2021 Oct; 22(4):1083. PubMed ID: 34447476
[TBL] [Abstract][Full Text] [Related]
14. Association of Helicobacter pylori infection with gastroesophageal reflux disease.
Jie W; Qinghong X; Zhitao C
J Int Med Res; 2019 Feb; 47(2):748-753. PubMed ID: 30453813
[TBL] [Abstract][Full Text] [Related]
15. Eradication of Helicobacter pylori infection might improve clinical status of patients with Parkinson's disease, especially on bradykinesia.
Liu H; Su W; Li S; Du W; Ma X; Jin Y; Li K; Chen H
Clin Neurol Neurosurg; 2017 Sep; 160():101-104. PubMed ID: 28704778
[TBL] [Abstract][Full Text] [Related]
16. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
Jankovic J; Stacy M
CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
[TBL] [Abstract][Full Text] [Related]
17. The Emerging Role of Helicobacter Pylori-Induced Metabolic Gastrointestinal Dysmotility and Neurodegeneration.
Kountouras J; Boziki M; Polyzos SA; Katsinelos P; Gavalas E; Zeglinas C; Tzivras D; Romiopoulos I; Giorgakis N; Anastasiadou K; Vardaka E; Kountouras C; Kazakos E; Giartza-Taxidou E; Deretzi G; Dardiotis E; Kotronis G; Doulberis M
Curr Mol Med; 2017; 17(6):389-404. PubMed ID: 29256351
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis: Association of Helicobacter pylori infection with Parkinson's diseases.
Shen X; Yang H; Wu Y; Zhang D; Jiang H
Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28598012
[TBL] [Abstract][Full Text] [Related]
19. Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson's disease.
Virmani T; Tazan S; Mazzoni P; Ford B; Greene PE
J Clin Mov Disord; 2016; 3():8. PubMed ID: 27231577
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical importance of Helicobacter pylori infection in patients after partial gastric resection for peptic ulcer disease. A prospective evaluation of Helicobacter pylori infection on 50 resected patients compared with matched nonresected controls.
Schilling D; Adamek HE; Wilke J; Schauwecker P; Martin WR; Arnold JC; Benz C; Labenz J; Riemann JF
Z Gastroenterol; 1999 Feb; 37(2):127-32. PubMed ID: 10190245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
